source
- Telix to acquire ITM Isotope for $1.65 billion, targeting radioligand therapy marketTelix Pharmaceuticals announced it will acquire ITM Isotope Technologies Munich for $1.65 billion upfront, securing a radiopharmaceutical supply network. The acquisition brings an R&D pipeline cen…
- White House considers executive order to politicize NIH grant approvalsSenior officials met in the Oval Office on Friday to discuss an executive order that would establish an external panel with authority to reject NIH grant applications. The meeting, reported by The…